Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab

por van der Schoot, Lara S., Atalay, Selma, Otero, Marisol E., Kievit, Wietske, van den Reek, Juul M.P.A., de Jong, Elke M.G.J.
Publicado 2022

Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study

por van Hal, Tamara W, Van den Reek, Juul MPA, Groenewoud, Hans MM, Pasch, Marcel C, Van den Hoogen, Frank HJ, Wenink, Mark H, De Jong, Elke MGJ
Publicado 2021

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

por Davidson, Linda, van den Reek, Juul M.P.A., Bruno, Mariolina, van Hunsel, Florence, Herings, Ron M.C., Matzaraki, Vasiliki, Boahen, Collins K., Kumar, Vinod, Groenewoud, Hans M.M., van de Veerdonk, Frank L., Netea, Mihai G., de Jong, Elke M.G.J., Kullberg, Bart Jan
Publicado 2021